Developing a vaccine is a time-consuming and complex process, requiring a combination of specialized skills and technical capacities not readily available at a single organization. TRANSVAC2, European Research Infrastructure project facilitates access to these skills and capacities across the vaccine R&D pipeline. For the last 3 years we supported over 40 projects from researchers worldwide to boost the development of their vaccines. Among granted projects we have supported human and veterinary vaccine candidates for infectious diseases (viral, including COVID-19; bacterial; parasitic), cancer, allergies and adjuvant development.
👩🔬 Are you a researcher? Do you have good preliminary results but you need support to further develop your vaccine candidate? TRANSVAC2 R&D services might be a perfect match for you! There is currently an ongoing Open Call for applications.
Check the latest call, service opportunities to boost the development of your vaccine candidates, events and opportunities . For all clickable links kindly download the attached PDF.
The newsletter is intended to inform our subscribers on open calls, services and training opportunities. Thank you for subscribing to our mailing list. If you have any questions or would like to unsubscribe contact us at transvacinfo@euvaccine.eu or contact.us@euvaccine.eu. TRANSVAC2 project is coordinated by European Vaccine Initiative (EVI).
This project has received funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement N° 730964.